Stephen Wanaski

629 total citations
20 papers, 527 citations indexed

About

Stephen Wanaski is a scholar working on Cognitive Neuroscience, Molecular Biology and Clinical Psychology. According to data from OpenAlex, Stephen Wanaski has authored 20 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cognitive Neuroscience, 6 papers in Molecular Biology and 5 papers in Clinical Psychology. Recurrent topics in Stephen Wanaski's work include Obsessive-Compulsive Spectrum Disorders (5 papers), Autism Spectrum Disorder Research (5 papers) and Sleep and Wakefulness Research (3 papers). Stephen Wanaski is often cited by papers focused on Obsessive-Compulsive Spectrum Disorders (5 papers), Autism Spectrum Disorder Research (5 papers) and Sleep and Wakefulness Research (3 papers). Stephen Wanaski collaborates with scholars based in United States. Stephen Wanaski's co-authors include Stuart McLaughlin, Michael Gläser, M. Gläser, Peng Luan, Benjamin Ng, Loren W. Runnels, Mario J. Rebecchi, Glenn D. Prestwich, Andrew J. Morris and Alan Aderem and has published in prestigious journals such as Journal of Biological Chemistry, Neurology and Biochemistry.

In The Last Decade

Stephen Wanaski

17 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Wanaski United States 7 387 173 71 45 41 20 527
Justin Yamada United States 8 776 2.0× 198 1.1× 55 0.8× 29 0.6× 33 0.8× 8 883
Maria E. Falzone United States 10 379 1.0× 110 0.6× 102 1.4× 77 1.7× 21 0.5× 15 453
Lars Thomas Germany 14 463 1.2× 143 0.8× 98 1.4× 144 3.2× 17 0.4× 19 584
Ángel Pérez-Lara Spain 13 486 1.3× 321 1.9× 92 1.3× 95 2.1× 17 0.4× 22 624
Jorge D. Cortese United States 14 449 1.2× 189 1.1× 55 0.8× 49 1.1× 55 1.3× 20 640
Noemi Jiménez‐Rojo Spain 11 361 0.9× 76 0.4× 77 1.1× 22 0.5× 38 0.9× 18 452
Dharini van der Hoeven United States 15 778 2.0× 221 1.3× 87 1.2× 57 1.3× 14 0.3× 30 1.1k
Georg Holtermann Germany 13 400 1.0× 116 0.7× 78 1.1× 39 0.9× 59 1.4× 21 671
Valérie Derrien France 13 443 1.1× 301 1.7× 86 1.2× 94 2.1× 64 1.6× 26 622
Byoung‐Cheol Lee South Korea 12 472 1.2× 109 0.6× 115 1.6× 121 2.7× 20 0.5× 29 578

Countries citing papers authored by Stephen Wanaski

Since Specialization
Citations

This map shows the geographic impact of Stephen Wanaski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Wanaski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Wanaski more than expected).

Fields of papers citing papers by Stephen Wanaski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Wanaski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Wanaski. The network helps show where Stephen Wanaski may publish in the future.

Co-authorship network of co-authors of Stephen Wanaski

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Wanaski. A scholar is included among the top collaborators of Stephen Wanaski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Wanaski. Stephen Wanaski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McGuire, Joseph, George B. Karkanias, Richard M. Bittman, et al.. (2025). Determining Clinically Meaningful Improvement in Children and Adolescents with Tourette Syndrome Receiving Pharmacotherapy. Journal of Child and Adolescent Psychopharmacology. 35(8). 447–453.
2.
Gilbert, Donald L., David J.B. Kim, Meredith Miller, et al.. (2025). Safety and Effect of 12‐Month Ecopipam Treatment in Pediatric Patients with Tourette Syndrome. Movement Disorders Clinical Practice. 12(8). 1157–1166.
3.
Gilbert, Donald L., et al.. (2023). Ecopipam for Tourette Syndrome: A Randomized Trial. PEDIATRICS. 151(2). 17 indexed citations
5.
Gilbert, Donald L., et al.. (2023). Design of a Phase 3 Maintenance-of-Effect Trial of Ecopipam in Tourette Syndrome (P12-11.011). Neurology. 100(17_supplement_2). 1 indexed citations
6.
Wanaski, Stephen, et al.. (2021). Cardiac Safety Profile of Pitolisant in Patients With Narcolepsy (1472). Neurology. 96(15_supplement). 1 indexed citations
7.
Winter, W, Stephen Wanaski, Albena Patroneva, & Jeffrey M. Dayno. (2020). 0744 Cardiac Safety Profile of Pitolisant in Patients with Narcolepsy. SLEEP. 43(Supplement_1). A283–A283. 2 indexed citations
8.
Doghramji, Karl, Craig W. Davis, Albena Patroneva, et al.. (2019). Pitolisant in combination with other medications for the management of narcolepsy. Sleep Medicine. 64. S94–S94. 1 indexed citations
9.
Doghramji, Karl, Craig W. Davis, Albena Patroneva, et al.. (2019). 0615 Pitolisant in Combination With Other Medications for the Management of Narcolepsy. SLEEP. 42(Supplement_1). A245–A245. 3 indexed citations
13.
Dubow, Jordan, et al.. (2016). Effect of deflazacort and prednisone on muscle enzymes in the treatment of Duchenne muscular dystrophy. Neuromuscular Disorders. 26. S180–S180. 1 indexed citations
14.
Eaddy, J. Scott, Kelly Rose, John M. Cullen, et al.. (2014). Liver biomarker and in vitro assessment confirm the hepatic origin of aminotransferase elevations lacking histopathological correlate in beagle dogs treated with GABAA receptor antagonist NP260. Toxicology and Applied Pharmacology. 277(2). 131–137. 26 indexed citations
15.
Verdoorn, Todd A., Andrew Whyment, Haifeng Wei, et al.. (2013). NP260, a novel GABA-A receptor antagonist, dampens neuronal hyperexcitability and relieves mechanical allodynia in a rat model of neuropathic pain. Journal of Pain. 14(4). S69–S69.
16.
Walzer, Mark, Ihor Bekersky, Stephen Wanaski, et al.. (2011). Oral toxicity of vigabatrin in immature rats: Characterization of intramyelinic edema. NeuroToxicology. 32(6). 963–974. 11 indexed citations
17.
Habtezion, Aida, Raymond Kwan, Maureen Morgan, et al.. (2010). Heme oxygenase-1 is induced in peripheral blood mononuclear cells of patients with acute pancreatitis: a potential therapeutic target. American Journal of Physiology-Gastrointestinal and Liver Physiology. 300(1). G12–G20. 21 indexed citations
18.
Wanaski, Stephen, Benjamin Ng, & Michael Gläser. (2002). Caveolin Scaffolding Region and the Membrane Binding Region of Src Form Lateral Membrane Domains. Biochemistry. 42(1). 42–56. 80 indexed citations
20.
Gläser, Michael, Stephen Wanaski, Carolyn A. Buser, et al.. (1996). Myristoylated Alanine-rich C Kinase Substrate (MARCKS) Produces Reversible Inhibition of Phospholipase C by Sequestering Phosphatidylinositol 4,5-Bisphosphate in Lateral Domains. Journal of Biological Chemistry. 271(42). 26187–26193. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026